Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 81, Topic 2
In Progress

Assessment and Classification of Pain in the Critically Ill

Lesson Progress
0% Complete
Assessment and Classification of Pain in the Critically Ill

Assessment and Classification of Pain in the Critically Ill

Objectives Icon A clipboard with a checkmark, symbolizing assessment and goals.

Objective

Apply diagnostic and classification criteria to assess pain in critically ill patients and guide initial management.

1. Initial Clinical Assessment

A structured history and focused physical exam are the cornerstones of pain assessment, even when communication is limited.

A. History (PQRST Framework)

A systematic approach to characterizing pain is crucial. The PQRST framework helps differentiate pain types and identify underlying causes.

  • Provocation/Palliation: What makes the pain worse or better? Identify triggers like movement or procedures, and note effective relief measures such as positioning or specific medications.
  • Quality: How does the pain feel? Characterize it as sharp, dull, stabbing, burning, or electric to help infer nociceptive versus neuropathic mechanisms.
  • Region/Radiation: Where is the pain and does it travel? Map the location and spread; radicular patterns are highly suggestive of neuropathic involvement.
  • Severity: How intense is the pain? Use self-report scales (0–10) whenever possible. For non-communicative patients, anticipate and document behavioral signs of distress.
  • Timing: Is the pain constant or intermittent? Note any association with procedures, and document exacerbating/relieving factors and responses to prior analgesics. Solicit collateral history from family or caregivers if the patient is unable to communicate.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Reassessment in Noncommunicative Patients

In noncommunicative patients, frequent reassessments (e.g., every 4 hours and after interventions) are essential to capture evolving pain patterns, evaluate therapeutic efficacy, and guide titration of analgesics.

B. Physical Examination

  • Inspection: Look for objective signs such as erythema, swelling, surgical wounds, drains, or abdominal distension.
  • Palpation: Localized tenderness accompanied by guarding indicates somatic pain. Rebound tenderness or rigidity suggests visceral causes and may signal a surgical emergency.
  • Neurologic Signs: In awake patients, test dermatomal sensation for allodynia or hyperalgesia. Assess reflexes and motor strength to identify deficits pointing to neuropathic pain.
  • Sedated Patients: Rely on validated behavioral scales during minimal sedation windows rather than isolated autonomic signs (tachycardia, hypertension), which are nonspecific.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Daily Sedation Interruption

Daily sedation interruptions (“sedation vacations”) are a critical opportunity to perform more accurate neurologic and pain examinations in intubated patients, allowing for self-reporting or more reliable behavioral assessments.

2. Diagnostic Modalities

Laboratory and imaging studies help confirm the etiology of pain, identify contraindications to certain therapies, and refine management plans.

A. Laboratory Tests

Key Laboratory Tests in Pain Assessment
Category Test Clinical Relevance
Inflammation/Infection WBC, CRP, Procalcitonin Identifies infectious or inflammatory sources of pain.
Organ Function LFTs, Creatinine/eGFR Guides selection and dosing of analgesics (e.g., opioids, NSAIDs).
Procedural Safety Platelets, PT/INR Assesses risk before considering regional or neuraxial anesthesia.
Neuromuscular Magnesium, Calcium Electrolyte abnormalities can influence nerve conduction and pain thresholds.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Abdominal Pain and Lactate

Refractory abdominal pain accompanied by rising lactate and elevated intra-abdominal pressure is a red flag for abdominal compartment syndrome or visceral ischemia. This requires urgent surgical consultation, not just opioid escalation.

B. Imaging and Specialized Procedures

Targeted imaging with ultrasound, CT, or MRI is used to detect underlying pathology such as abscesses, ischemia, compartment syndrome, or other structural lesions. When feasible and safe, point-of-care ultrasound can guide diagnostic and therapeutic procedures like nerve blocks.

3. Pain Classification Systems

Classifying pain by its duration and underlying mechanism is fundamental to selecting an appropriate therapeutic strategy and setting realistic expectations.

A. Classification by Duration

Pain Classification by Duration
Duration Typical Cause Management Strategy
Acute (<1 month) Tissue injury, procedural pain Responsive to short-course, titratable analgesia (e.g., opioids).
Subacute (1–3 months) Transition phase, risk of central sensitization Introduce multimodal strategies; monitor for chronification.
Chronic (>3 months) Neural adaptations, central sensitization Focus on function, opioid stewardship, nonpharmacologic therapies.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Predicting Chronicity

Pain that persists beyond the expected healing period (typically >6 weeks) is a strong predictor of chronicity. Early involvement of an interdisciplinary pain service may prevent the development of long-term pain syndromes.

B. Classification by Etiology

  • Nociceptive Somatic: Arises from injury to skin, muscle, or bone. Typically described as sharp and is well-localized.
  • Nociceptive Visceral: Originates from internal organs. Often described as dull, aching, or cramping and is poorly localized. May be associated with autonomic features like nausea or sweating.
  • Neuropathic: Caused by a lesion or disease of the somatosensory nervous system. Described as burning, electric, or shooting pain and is often associated with sensory changes. Requires adjuvant agents like gabapentinoids or SNRIs.
  • Mixed: A combination of nociceptive and neuropathic features. Requires a multimodal approach combining traditional analgesics with neuropathic adjuvants.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Mixed Pain Post-Thoracotomy

Post-thoracotomy pain is a classic example of mixed pain, involving somatic (incision) and neuropathic (intercostal nerve injury) components. Recognizing this early and adding gabapentinoids can reduce opioid requirements and improve respiratory mechanics by better controlling pain during deep breathing.

4. Severity and Behavioral Scales

Validated scoring tools are essential for quantifying pain, guiding protocolized interventions, and ensuring consistent communication among the care team.

A. Self-Report Scales

When a patient can communicate, self-report is the gold standard. The Numeric Rating Scale (NRS) is preferred for its simplicity and responsiveness.

  • Numeric Rating Scale (NRS): A 0–10 scale where 0 is “no pain” and 10 is the “worst imaginable pain.” Scores ≥4 are typically considered moderate-to-severe pain requiring intervention.
  • Visual Analog Scale (VAS): A 10 cm line where the patient marks their pain level. It is more granular but less practical for frequent use in critically ill or cognitively impaired patients.

Key Point: Protocols that trigger an intervention (e.g., increase opioid infusion by 20%) for an NRS score ≥4 and consider de-escalation for scores ≤2 can standardize care and limit both under- and over-treatment.

B. Behavioral Scales for Non-Communicative Patients

For sedated, intubated, or delirious patients, validated behavioral scales are the standard of care.

Comparison of Behavioral Pain Scales
Scale Score Range Domains Assessed Intervention Threshold
Behavioral Pain Scale (BPS) 3–12 Facial Expression, Upper Limb Movement, Compliance with Ventilator Score > 5 indicates significant pain
Critical-Care Pain Observation Tool (CPOT) 0–8 Facial Expression, Body Movement, Muscle Tension, Compliance (intubated) or Vocalization (extubated) Score > 2 indicates significant pain

Key Point: Combine BPS/CPOT assessments with sedation scales (e.g., Richmond Agitation-Sedation Scale, RASS) during sedation interruptions. This allows clinicians to distinguish pain from agitation and optimize both analgesia and sedation independently.

5. Risk Stratification and Urgency

Early identification of risk factors, functional goals, and contraindications allows for the development of tailored analgesic pathways.

A. Functional Goals and Opioid Tolerance

  • Define patient-centered functional goals, such as the ability to participate in mobilization, cooperate with spontaneous breathing trials, or rest comfortably.
  • Assess for baseline opioid exposure and tolerance. High-tolerance patients may require higher doses, opioid rotation, or the addition of adjuvant infusions (e.g., ketamine) to achieve adequate analgesia.

B. Contraindications to Analgesic Therapies

  • Regional/Neuraxial Techniques: Contraindicated by coagulopathy (e.g., platelets <100×10⁹/L, INR >1.5) or infection at the proposed block site.
  • Renal Impairment: Severe renal dysfunction (e.g., eGFR <30 mL/min) favors the use of fentanyl or hydromorphone over morphine due to the risk of active metabolite accumulation.
  • Hepatic Dysfunction: Requires careful dose adjustments for most opioids and adjuvant medications, particularly methadone and certain antidepressants.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Analgesia in Coagulopathy

In patients with coagulopathy where regional techniques are unsafe, a low-dose ketamine infusion can be an excellent opioid-sparing adjuvant. It provides potent analgesia via NMDA-receptor blockade without affecting coagulation.

6. Documentation and Electronic Health Record Integration

Standardized templates and automated triggers within the electronic health record (EHR) are crucial for ensuring consistency, compliance, and continuous quality improvement in pain management.

A. Standardized Templates and Flow Sheets

  • Incorporate parallel fields for pain scores (NRS/BPS/CPOT), sedation scores (RASS), and details of all analgesic therapies.
  • Use dropdown menus with standardized descriptors (e.g., sharp, burning, dull) to harmonize terminology across providers.
  • Embed audit logs to track assessment frequency and interprofessional compliance with pain management protocols.

B. Reassessment Triggers and Clinical Decision Support

  • Configure the EHR to send an automated alert to the nursing and prescribing team for high pain scores (e.g., NRS ≥4, BPS >5, or CPOT >2).
  • Build escalation and de-escalation logic into order sets. For example, define thresholds for increasing an infusion (e.g., by 10–20%) or for considering a reduction after a sustained period of adequate pain control.
  • Balance alert sensitivity to provide timely reminders without causing alarm fatigue. Allow for clinician override with a required justification.

References

  1. Payen JF, Bru O, Bosson JL, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med. 2001;29(12):2258–2263.
  2. Gélinas C, Joffe AM, Szumita PM, et al. The Forgotten Problem of Pain in the ICU and Its Impact on Recovery. AACN Adv Crit Care. 2019;30(4):365–379.
  3. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
  4. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825–e873.
  5. Nordness MF, Puntillo KA. Pain in the Critically Ill Patient. Crit Care Clin. 2021;37(2):273–285.
  6. Dowell D, Ragan KR, Jones CM, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep. 2022;71(3):1–95.
  7. Henson LA, Maddocks M, Evans C, et al. Palliative Care and the Management of Common, Distressing Symptoms in Advanced Cancer: A Systematic Review. J Clin Oncol. 2020;38(9):905–914.